The identification of a potent, water soluble inhibitor of lipoprotein-associated phospholipase A2
- 8 March 2001
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 11 (5) , 701-704
- https://doi.org/10.1016/s0960-894x(01)00038-5
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- N-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2Bioorganic & Medicinal Chemistry Letters, 2000
- Lipoprotein-Associated Phospholipase A2as an Independent Predictor of Coronary Heart DiseaseNew England Journal of Medicine, 2000
- 2-(Alkylthio)pyrimidin-4-ones as novel, reversible inhibitors of lipoprotein-associated phospholipase A 2Bioorganic & Medicinal Chemistry Letters, 2000
- Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitorBiochemical Journal, 1999
- Current and future treatment of hyperlipidemia: the role of statinsThe American Journal of Cardiology, 1998
- Expression, purification and characterization of a human serine-dependent phospholipase A2 with high specificity for oxidized phospholipids and platelet activating factorBiochemical Journal, 1998
- Purification, Properties, Sequencing, and Cloning of a Lipoprotein-Associated, Serine-Dependent Phospholipase Involved in the Oxidative Modification of Low-Density LipoproteinsArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Mild homogeneous deblocking employing 2-bromo-1,3,2-benzodioxaborole1Tetrahedron Letters, 1985